This is an audio transcript of the Behind the Money podcast episode: ‘Not everyone will win in Trump’s M&A revival’ Michela ...

"To my mind, all of this public input and engagement made our work sharper and helped us really set priorities and focus on ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

Margin expansion at Express Scripts, Caremark and Optum Rx increased by $336 million between 2017 and 2021, officials say.

A report from the Federal Trade Commission (FTC) has determined that pharmacy benefit managers (PBMs) are linked to significant cost increases for cancer, HIV, and other critical specialty drugs.

While Greystar maintains it has been proactive in improving fee disclosures and promoting transparency, the company noted the ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over ...

The FTC is weighing a lawsuit alleging Greystar failed to disclose fees related to trash services and background checks .

On Friday, January 10, 2025, the Chamber of Commerce, Business Roundtable, American Investment Council, and Longview Chamber of Commerce filed ...

It takes effect Tuesday but its fate is already in doubt. The new FTC rule faces legal challenges and possible opposition ...

Noonan, a former FTC regulator, didn’t foresee the agency giving up on auto retail regulation during the second Trump ...